The FDA approved adaptive deep brain stimulation (DBS) technology (BrainSense adaptive DBS and BrainSense electrode ...

Medtronic (NYSE:MDT) has won FDA approval for a deep brain stimulation system for Parkinson’s disease. The approval is for ...

Brain scientists have developed DeepFocus, a novel technique to reach the deep brain without invasive surgery to treat mental ...

The FDA approved Medtronic's BrainSense Adaptive DBS and Electrode Identifier for Parkinson's, enhancing therapy ...

Researchers from Carnegie Mellon University and Allegheny Health Network have developed a new method for deep brain ...

Medtronic (MDT) announced FDA approval of BrainSense Adaptive deep brain stimulation – aDBS – and BrainSense Electrode Identifier. There is no ...

Carnegie Mellon researchers developed "DeepFocus," a new method for brain stimulation that combines transnasal and transcranial electrical stimulation for minimally invasive targeting of deep brain ...

With the platform HoloSNS — created by Professor of Biomedical Engineering Cameron McIntyre and his team — physicians and ...

Medtronic said the Food and Drug Administration approved a brain stimulation system for people afflicted with Parkinson's disease.

Shortly after obtaining a greenlight in Europe and after more than 10 years in development, Medtronic has now received the ...

The BrainSense adaptive deep brain stimulation system personalizes therapy by dynamically adjusting stimulation based on real ...

The FDA has approved adaptive deep brain stimulation (aDBS) for Parkinson’s disease, marking a breakthrough in treatment. This therapy continuously monitors brain activity and delivers targeted ...